Top

Published in:

04-09-2023 | Colonoscopy | COMMENTARY

Interpreting epidemiologic studies of colonoscopy screening for colorectal cancer prevention: understanding the mechanisms of action is key

Authors: Mingyang Song, Michael Bretthauer

Published in: European Journal of Epidemiology | Issue 9/2023

Excerpt

Colorectal cancer (CRC) is the second leading cause of cancer-related death in the world. Colonoscopy screening is a screening test that can both prevent CRC by detecting and removing precancerous polyps, and detect cancer at an early, curable stage. Colonoscopy has become the predominant CRC screening test in the United States, where 61% of screening-eligible adults have undergone colonoscopy screening, compared to only 11% who chose stool-based tests [1]. …

American Cancer Society. Colorectal Cancer Facts & Figures 2020–2022. Atlanta: American Cancer Society; 2020.

Brenner H, Stock C, Hoffmeister M. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. BMJ. 2014;348:g2467. https://doi.org/10.1136/bmj.g2467.CrossRefPubMedPubMedCentral

Bretthauer M, Loberg M, Wieszczy P, et al. Effect of colonoscopy screening on risks of colorectal cancer and related death. N Engl J Med. 2022;387(17):1547–56. https://doi.org/10.1056/NEJMoa2208375.CrossRefPubMed

Juul FE, Cross AJ, Schoen RE, et al. 15-year benefits of sigmoidoscopy screening on colorectal cancer incidence and mortality : a pooled analysis of randomized trials. Ann Intern Med. 2022;175(11):1525–33. https://doi.org/10.7326/M22-0835.CrossRefPubMed

Dominitz JA, Robertson DJ. Understanding the results of a randomized trial of screening colonoscopy. N Engl J Med. 2022;387(17):1609–11. https://doi.org/10.1056/NEJMe2211595.CrossRefPubMed

Patz EF Jr, Goodman PC, Bepler G. Screening for lung cancer. N Engl J Med. 2000;343(22):1627–33. https://doi.org/10.1056/NEJM200011303432208.CrossRefPubMed

Hanley JA. Measuring mortality reductions in cancer screening trials. Epidemiol Rev. 2011;33:36–45. https://doi.org/10.1093/epirev/mxq021.CrossRefPubMed

Brenner H, Chang-Claude J, Jansen L, Knebel P, Stock C, Hoffmeister M. Reduced risk of colorectal cancer up to 10 years after screening, surveillance, or diagnostic colonoscopy. Gastroenterology. 2014;146(3):709–17. https://doi.org/10.1053/j.gastro.2013.09.001.CrossRefPubMed

Nishihara R, Wu K, Lochhead P, et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med. 2013;369(12):1095–105. https://doi.org/10.1056/NEJMoa1301969.CrossRefPubMed

Title: Interpreting epidemiologic studies of colonoscopy screening for colorectal cancer prevention: understanding the mechanisms of action is key
Authors: Mingyang Song
Michael Bretthauer
Publication date: 04-09-2023
Publisher: Springer Netherlands
Keywords: Colonoscopy
Colorectal Cancer
Colorectal Cancer
Published in: European Journal of Epidemiology / Issue 9/2023
Print ISSN: 0393-2990
Electronic ISSN: 1573-7284
DOI: https://doi.org/10.1007/s10654-023-01043-y

2024 ASCO Annual Meeting

Springer Medicine

Interpreting epidemiologic studies of colonoscopy screening for colorectal cancer prevention: understanding the mechanisms of action is key

Excerpt

2024 ASCO Annual Meeting

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 9/2023

Incidence, prevalence and mortality of chronic liver diseases in Sweden between 2005 and 2019

The pregnancy research on inflammation, nutrition, & city environment: systematic analyses study (PRINCESA) cohort, 2009–2015

Associations of polygenic inheritance of physical activity with aerobic fitness, cardiometabolic risk factors and diseases: the HUNT study

Reappraising the role of instrumental inequalities for mendelian randomization studies in the mega Biobank era

Prevalence of incidental colorectal cancer and polyps in autopsies of different populations: a systematic review with meta-regression analysis

About the associations of vitamin D deficiency and biomarkers of systemic inflammatory response with all-cause and cause-specific mortality in a general population sample of almost 400,000 UK Biobank participants